2025 annual financial data
Tvardi Therapeutics 2025 Operating margin
Tvardi Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -26,748,000 USD and net income was -18,214,000 USD.
Operating cash flow was -23,499,000 USD.
Get free Tvardi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,748,000 USD
- Net income
- -18,214,000 USD
- Operating cash flow
- -23,499,000 USD